Evidence map›Paper›PMID 40195414›Full record

ArticleScientific reports2025

Region-specific brain decellularized extracellular matrix promotes cell recovery in an in vitro model of stroke.

Diego Reginensi, Didio Alberto Ortiz, Bernardino Denis, Solangel Castillo, Andrea Burillo, Nathalie Khoury, Jing Xu, Maria Lucia Dam, Anthony A Hurtado Escobar, Kunjan R Dave and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Biomaterials in organoid research: current state and future directions.Frontiers in bioengineering and biotechnology · 2026
    Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Diego ReginensiCenter for Biodiversity and Drug Discovery, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), Panama, Panama.
Didio Alberto OrtizCenter for Biodiversity and Drug Discovery, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), Panama, Panama.
Bernardino DenisCenter for Biodiversity and Drug Discovery, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), Panama, Panama.
Solangel CastilloAdvanced Therapies, School of Medicine, Universidad de Panamá (UP), Panama, Panama.
Andrea BurilloCenter for Biodiversity and Drug Discovery, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), Panama, Panama.
Nathalie KhouryNeuroscience Program, University of Miami Miller School of Medicine, Miami, FL, USA.
Jing XuNeuroscience Program, University of Miami Miller School of Medicine, Miami, FL, USA.
Maria Lucia DamCenter for Biodiversity and Drug Discovery, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), Panama, Panama.
Anthony A Hurtado EscobarCenter for Biodiversity and Drug Discovery, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), Panama, Panama.
Kunjan R DaveNeuroscience Program, University of Miami Miller School of Medicine, Miami, FL, USA.
Miguel A Perez-PinzonNeuroscience Program, University of Miami Miller School of Medicine, Miami, FL, USA.
Rolando A GittensCenter for Biodiversity and Drug Discovery, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), Panama, Panama. rgittens@itse.ac.pa.

Funding

Decellularized Extracellular Matrix Biomaterials as Therapy to Ameliorate Cerebral Ischemia DamageR21NS098896 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PEREZ-PINZON, MIGUEL A · 2016 to 2017
$339k
NINDS NIH HHS 1R21NS098896-02NINDS NIH HHS R21 NS098896Secretaría Nacional de Ciencia, Tecnología e Innovación DDCCT-No-101-2021Secretaría Nacional de Ciencia, Tecnología e Innovación FID17-078Sistema Nacional de Investigación, Secretaría Nacional de Ciencia, Tecnología e Innovación Res-84-2022Sistema Nacional de Investigación, Secretaría Nacional de Ciencia, Tecnología e Innovación SNI-051-2023
6 · The paper itself

Abstract

Brain decellularized extracellular matrix (ECM) can be an attractive scaffold capable of mimicking the native ecosystem of the central nervous system tissue. We studied the in vitro response of neural cultures exposed to region-specific brain decellularized ECM scaffolds from three distinct neuroanatomical sections: cortex, cerebellum and remaining areas. First, each brain region was evaluated with the isotropic fractionator method to understand the cellular composition of the different cerebral areas. Second, the cerebral regions were subjected to the decellularization process and their respective characterization using molecular, histological, and ultrastructural techniques. Third, the levels of neurotrophic factors in the decellularized brain scaffold were analyzed. Fourth, we studied the region-specific brain decellularized ECM as a mimetic platform for the maturation of PC12 cells, as a unidirectional model of differentiation. Finally, in vitro studies were carried out to evaluate the cell recovery capacity of brain decellularized ECM under stroke-mimetic conditions. Our results show that region-specific brain decellularized ECM can serve as a biomimetic scaffold capable of promoting the growth of neural lineage cells and, in addition, it possesses a combination of structural and biochemical signals (e.g., neurotrophic factors) that are capable of inducing cell phenotypic changes and promote viability and cell recovery in a stroke/ischemia model in vitro.

Indexed as

BrainDecellularized Extracellular MatrixExtracellular MatrixStrokeAnimalsCell DifferentiationNeuronsPC12 CellsRatsTissue ScaffoldsDecellularized Extracellular MatrixBrain extracellular matrixDecellularized scaffoldOxygen-glucose deprivation (OGD).Tissue engineering

Identifiers

PMID40195414
PMCPMC11976941

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.